3rd July 2026, Friday

TechPharus

Latest Posts

HealthTech News

  • Molecules link lower weight babies and chronic diseases
    on July 3, 2026 at 4:00 pm

    Researchers have long sought to discover why babies who weigh less than expected at birth, a condition known as small for gestational age, or SGA, are at higher risk for heart, lung and metabolic diseases as adults.

  • AI tool improves prediction of who will respond to cancer immunotherapy drugs
    on July 3, 2026 at 3:40 pm

    Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others. But these drugs work for only a subset of patients, with few indications why—a knowledge gap that has detrimental effects on patient prognosis, clinical trial recruitment and research that could lead to new therapies.

  • Decade-long national study finds antimicrobial use in Australian hospitals improves with regular monitoring
    on July 3, 2026 at 3:20 pm

    A 10-year national study has found improved antimicrobial use in Australian hospitals that regularly monitored their prescribing, using a globally unique program developed by a Melbourne hospital. The study reinforces the importance of antimicrobial stewardship to improve patient care and minimize antimicrobial resistance.

  • Are lung cancer tumors hijacking the nervous system?
    on July 3, 2026 at 3:20 pm

    According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.

  • New tumor map identifies high-risk B-cell lymphoma standard therapy may miss
    on July 3, 2026 at 3:00 pm

    Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized. By combining genetic and proteomic analyses, the scientists identified biological characteristics of tumors, particularly in high-risk patients for whom standard therapy offers little chance of cure. In the future, such patients could receive alternative, more effective therapies directly. In addition, experimental laboratory research provided initial clues to potential therapeutic targets. The study is published in Cancer Cell.